Per Byström

Novartis (Sweden) — Sweden

Medicine · Health Sciences

13h-index1.1kcitations22works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(11), Hepatocellular Carcinoma Treatment and Prognosis(6), Colorectal and Anal Carcinomas(6), Pancreatic and Hepatic Oncology Research(4), Gastric Cancer Management and Outcomes(4)

Publications22 total

A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib
BMC Cancer·2016· 42 citedOpen Access
Evaluation of predictive markers for patients with advanced colorectal cancer
Acta Oncologica·2012· 38 citedOpen Access
Health-related quality of life in patients with metastatic colorectal cancer receiving palliative combination chemotherapy
2012· 3 cited
The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy
Annals of Oncology·2011· 106 citedOpen Access
Initial change in tumor size as an imaging surrogate of outcomes in patients with metastatic colorectal cancer (mCRC) treated with first-line irinotecan and 5-FU combination chemotherapy.
Journal of Clinical Oncology·2011
Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer
The Pharmacogenomics Journal·2010· 121 citedOpen Access
Colorectal cancer treatment and early response evaluation, how do we best evaluate treatment response?
Figshare·2010Open Access
High Plasma TIMP-1 and Serum CEA Levels during Combination Chemotherapy for Metastatic Colorectal Cancer Are Significantly Associated with Poor Outcome
Oncology·2010· 22 cited
Long-term follow-up of chemonaive patients with asymptomatic metastatic colorectal cancer treated with enzastaurin in a window of opportunity phase II study
Annals of Oncology·2009· 6 cited
A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer
Annals of Oncology·2009· 25 cited
Reply to FDG–PET: for early prediction of response to the first-line chemotherapy in metastatic colorectal cancer?
Annals of Oncology·2009Open Access
An explorative randomised phase II study of sequential chemotherapy in advanced upper gastrointestinal cancer
Medical Oncology·2009· 7 cited
Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer
Annals of Oncology·2009· 71 citedOpen Access
Serum vitamin B12 and folate status among patients with chemotherapy treatment for advanced colorectal cancer
Upsala Journal of Medical Sciences·2009· 21 citedOpen Access
Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: The CORGI-L study
European Journal of Cancer·2008· 21 cited
Randomized Phase III Study Comparing Preoperative Radiotherapy With Chemoradiotherapy in Nonresectable Rectal Cancer
Journal of Clinical Oncology·2008· 478 citedOpen Access
A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer
Annals of Oncology·2008· 48 citedOpen Access
Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma
Acta Oncologica·2008· 34 citedOpen Access
TIMP-1 Is Significantly Associated with Objective Response and Survival in Metastatic Colorectal Cancer Patients Receiving Combination of Irinotecan, 5-Fluorouracil, and Folinic Acid
Clinical Cancer Research·2007· 77 citedOpen Access
Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma
Journal of Clinical Oncology·2007
page 1 of 2Next →

Frequent Co-authors

Åke Berglund(15), Bengt Glimelius(15), Jan‐Erik Frödin(5), Peter Nygren(4), Anders Sundin(3), Hans Jacobsson(3), Per Pfeiffer(3), Birgitta Johansson(3), Anders Johnsson(3), Kjell M. Tveit(2), Lars Påhlman(2), Hans Garmo(2), Halfdan Sørbye(2), Takayuki Suzuki(2), Lennart Blomqvist(2), Ib Jarle Christensen(2), Hans Jørgen Nielsen(2), Anders Larsson(2), Pehr Lind(2), Markus Almström(2)